Propel Bio Management, LLC
Position in AQST — Aquestive Therapeutics, Inc.
CIK 1969764
LOS ANGELES, CA
Position in AQST
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,000,371
+$3,049,771 QoQ
Shares Held
1,442,397
+102.9% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
3.14%
of 13F equity value
Holder Rank
#11
of 185 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 81%
Shared 19%
None 0%
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Propel Bio Management, LLC holds $8,212,326 across 2 Drug Manufacturers - Specialty & Generic names. AQST ranks #1 (73.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AQST |
Aquestive Therapeutics, Inc.
This page
|
1,442,397 | $6,000,371 | |
| 2 | SCYX |
Scynexis Inc
|
543,478 | $2,211,955 |
All Filings in AQST
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,000,371 | 1,442,397 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,950,600 | 710,988 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||